chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Localized reaction to MMRV SQ injection site. Treated with topical triamcinolone, ice, and PO benadryl.
Warm to touch upper left deltoid, large size swollen knot that is red on upper left deltoid, it seems to be getting larger.  first noticed on 01/06/21 about 4:30 pm and as of today 1/08/21  the area is still swollen, red and warm to touch.
High fever and convulsions 9 hours after injection.  Diagnosed with shingles 48 hours after injection,  within another 48 hours violent vomiting and fever ensued and individual was diagnosed with viral meningitis and neutropenia.  7 days later individual was diagnosed with blood clots in arm and leg.  Outcome is yet to be determined.
Day 1: Malaise, crying, refusing to walk, temp 100-101, loss of appetite. Day 2: Malaise, crying, fatigue, loss of appetite. Day 3: Vomiting. Day 4: Diarrhea. Day 5: Vomiting and diarrhea.
no adverse event; Pharmacist reported that adult patient received a pediatric dose of VAQTA; This spontaneous report was received from a pharmacist concerning a 30 years old adult patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 18-NOV-2022, the adult patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA), lot number w021491 with expiration date 14-DEC-2023, 0.5 millilitre (mL) dose, once for prophylaxis (strength, route of administration and anatomical location were not provided) (product administered to patient of inappropriate age). No adverse events (AEs) were reported(no adverse event).  This is one of two reports received from the same reporter. ; Sender's Comments:  US-009507513-2212USA002445:
pt recv vax  9OCT96 & next day exp soreness @ both sites;9OCT96 PM exp elevated temp of 102 x 24hr;11OCT96 exp small pustules @ inj site;12hr later pustules, along w/rash, spread to rt & lt thighs, abd at navel, forearms, itching noted;
Hives, vomiting fever. All began few hours after vaccines given. Started on Benadryl - sx's resolved
It has taken me months to finally feel like I am okay. The second dose started with a fever the night of vaccination, Friday night. I didn't feel sick, I just felt hot. Then the following day, on Saturday, I was taking Tylenol and could not get below 103 degrees. I contacted my insurance company that has a nurse and they told me to go to ER. My joints had started hurting very bad, it felt like I had just had surgery. I went to the urgent care, they evaluated me and told me to go to the ER. I went to the ER and was there maybe 3-4 hours. They gave me IV fluids and gave me lab work and sent me on my way, they said everything was normal but it wasn't. Another physician did tests and the lab work they got was different, they got results with protein and he told me to go to the ER to get a CAT scan. Then that hospitalization was about 8 hours and that Cat scan was negative. Then I had extensive bloodwork 2-3 weeks after the vaccine and all of my inflammatory panels were elevated. A gastroenterologist ordered this test and my cholesterol was elevated. I then started having pain in my left lung and it hurt when I breathed in. I had x-rays that did not show up with anything. I then developed more joint pain, which I had to take pain killers for. My DR had never seen levels like these before and all of this basically lasted until about two weeks ago. I also had a stabbing pain in my right arm and got an ultrasound which came back negative for any blood clots. I have literally gone from DR to DR to DR to DR to DR, it is hard to remember everything. I have seen specialists and also spoke to a cardiologist a couple days ago. He said I inflammation around my heart as well, I was not surprised, I was totally in pain everything hurt. One thing at least 4 DRs said to me, they asked me if I had Covid and I said not that I know of. I never had a positive covid test and didn't have an antibody test until Nov of 2020, when the speculation of my having covid would've been Feb 2020.
At 24 hrs after vaccination, seen in office with left deltoid region has a small area of warmth, mild swelling and erythema. Afeb.
Patient described becoming "achy" all over and had "typical flu symptoms" over a 2 week period.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 10:47 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 10:47 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 43.68 Concomitant medication was not provided.  On 15-Apr-2021, Excursion time was 09 AM temperature was 34 total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 06-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 09-May-2021.  On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 AM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
pain at injection site. redness surrounding- 9 x 4cm. plus fever 100.3
Client states her left arm swelled and lymphnodes in L axilla swelled. States she was diagnosed with cellulitis by her primary care Physician on 4/10/19.
Patient presented to the ED and was subsequently hospitalized on 3/20/21, 3/26/21, and 4/17/21. He also had an ED visit on 4/15/21.
Since I have received the first dose injection of the Pfizer BioNTech vaccine i have been have persistent  mild to medium tinnitus in both ears. Its seems that it  can change in how noticable the ring in my ears is.
Pt states shot was given too high on her arm.  She started 6 days later with pain to the left shoulder joint.  She is unable to raise her arm laterally above 85 degrees and anteriorly to 45 degrees only.  No pain, weakness, or numbness.  Has pain with movement of left arm and even if sitting still.  xray has been ordered and NSAIDS started.  Pt seen today 10/3 for the first time.   Has significant pain and limitations to movement.
Patient fainted 10 minutes after receiving the 2nd COVID vaccine. Has some jerking movements while unconscious. She was very nervous beforehand. Recovered after 1-2 minutes, was feeling fine, didn't remember the event, had normal vital signs and exam by physician. Went to clinic and was observed for 2 hours, no repeat reactions.
low grade fever (100.5 F), irritability, stomach discomfort and soreness at injection site
Parotitis Narrative: Employee stopped by Occupational Health and reported the side effect of the vaccine. She reported that her parotitis occurred early November and has not been resolved yet.
6 cm x 7 cm area of erythema with slight induration, minimally tender.
PATIENT HAD PFIZER COVID VACCINE ON  Dose 1 date: 01/07/2021, Dose 2 date: 01/28/2021, AND TESTED POSITIVE TO COVID.
Patient began having weakness on one side of his face- His wife took him to the ER and they found that he had Bell's Palsy. He was started on prednisone 60 mg daily for 5 days and valacyclovir 1 gm three times daily for 7 days. He was just started on this treatment today (4-17-21) but his symptoms started yesterday (4-16-21).
Received the vaccine on Saturday, 4/10/2021 at around 12p. On Sunday, 4/11/2021 woke up around 11am with a fever and feeling extremely run down. In addition had no appetite and somewhat nauseas.  On Monday morning around 10am, felt better with no fever yet still less of an appetite. Through out the day kept improving and then at 12:30a Tuesday, 4/12/21 I began to get hives on my inner thighs, arms, feet, buttocks which started to rapidly spread to all over my body. After about an hour my lips swelled up and the hives were puffier and immensely itchy and painful including my arms and feet. On
Pt reported body rash/hives- itching . Strated 03/26, worse 03/27
There  have been two adverse events to address:  1. I first felt terrible, flu-ish a little after 24 hours from first dose. I also had a fever of 103.7. This lasted about 36 hours until I started feeling moderate again.   2. Secondly I wanted to mention that I have had a sore throat upon waking every morning since I have gotten the vaccine. Potentially this is not from the vaccine, I realize, but I wanted to address it.
BODY ACHES; DIARRHEA; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 47 year old female. The patient's weight, height, and medical history were not reported. The patient experienced drug allergy when treated with naproxen sodium, and acetylsalicylic acid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 to right arm for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced body aches. On 02-APR-2021, the subject experienced diarrhea. On 02-APR-2021, the subject experienced chills. On 02-APR-2021, the subject experienced headache. On 02-APR-2021, the subject experienced fever. Treatment medications included: diphenhydramine hydrochloride, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and fever, and the outcome of body aches, headache and diarrhea was not reported. This report was non-serious.
right eye redness  and pain starting 1 hour after  vaccine. patient came to see me the following day and her diagnosis is nodular scleritis right eye.
Patient was fully vaccinated, had dose one on 12/22/2020 and second dose on 1/12/21.  Tested positive for covid on 5/7/21.
pt recv vax 12OCT96 & by that evening pt had devel redness & nodular swelling @ the inj site;the next day 13OCT96 it was reported that site had swollen to the size of a baseball was red & sore;
Guillain Barre Syndrome; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient received Shingles vaccine and got guillain barre syndrome and could not get any vaccines, till the time of reporting. The patient stated he/she could not get Covid vaccine and be protected. The follow-up would not be possible as no contact details were available.
Mild itch rash at R neck, given 1 dose of cetirizine 10 mg tab.  Itchiness improved after 20 minutes
Client came into local vaccination site for 1st booster of Pfizer COVID-19 vaccine. Patient was checked in appropriately. Pfizer 1st COVID-19 booster vaccine (0.3mL) lot # FP7139 was administered in the left deltoid at 1413 by RN. Client was then asked to wait in the observation area for 15 minutes. At 1416, client reported feeling "a little dizzy" to RN at the post-vaccination observation area. RN offered client the zero-gravity chair immediately. Both Nurses assessed the patient and vital signs were obtained at 1419 as follows: BP 115/98, HR 58, RR 16, Temp 97.4 degrees Fahrenheit, Oxygen sat 96%. After 2 minutes of being in the zero-gravity chair, client stated "I feel better now". Client is alert and oriented x4 and verbally responsive. During assessment by both Nurses client was noted to be sweating on the forehead and was wearing a baseball cap. Client denied any medical concerns and denied experiencing pain, headache, chills and stated, "It's hot outside". Client also reported that he normally would feel anxious whenever he sees needles and was unsure if that is also a contributing factor to his current dizziness. Client also reported that he had not eaten since dinner last night. Client was offered water and crackers which he consumed right away. Client denied experiencing any pain, headache or discomfort. Subsequent vitals were obtained at 1425 as follows:  BP 131/77, HR 65, RR 16, Temp 97.0 degrees Fahrenheit, Oxygen sat 98%. At 1430 client was joined by his wife and 2 children in the observation area.  Nurse noted that client's visibly sweating forehead had cleared. Client continued to deny any discomfort and continued to deny feelings of dizziness. At 1450 repeat vitals were taken as follows: BP 135/80, HR 72, Temp 97.9 degrees Fahrenheit, Oxygen sat 96%. Client was encouraged by Nurse to eat as soon as possible and to continue drinking fluids after leaving the vaccination site. Client was also encouraged by Nurse to follow up with his Primary Care Physician as needed and to call 911 for any emergencies. Client verbalized understanding and left vaccination site.  Nurse observed client walk away from vaccination site accompanied by his family, with steady gait and balance.
She's seen serious injuries occur following receipt of the covid vaccine/knows of a 30 year old who now has a heart condition; She's seen serious injuries occur following receipt of the covid vaccine/knows of a 30 year old who now has a heart condition; This is a spontaneous report from a non-contactable Other HCP from a Pfizer sponsored program. A 30-years-old patient of unspecified gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced and states that she's seen serious injuries occur following receipt of the covid vaccine and reported that the knows of a 30-year-old who now had a heart condition and was denied help by Pfizer. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I have been to the ER twice--once with significant heart palpitations and angina mimicking heart attack symptoms and once with angina and ear ringing mimicking stroke symptoms.   Ongoing stage 2 hypertension.
Patient had 6 circular bumps with clear, small blisters in them on the opposite arm on the inner bicep, the wrist, and back of hand.  The bumps were itchy. The bumps began 24 hours after the immunization.
4/14 injection site pain, swelling and numbness for 2+ days 4/14 whole body fatigue, muscle pain, joint aching, couldn't move from bed other than to bathroom and bed for 36 hours
Breakthrough case admission after 2 vaccines  Modern a1/27/21 Lot# 039K20A;  Modern 2/23/21 Lot# 004M20A
Sore right arm; Achy body; Tiredness; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Sore right arm), MYALGIA (Achy body) and FATIGUE (Tiredness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026D21A and 056M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced VACCINATION SITE PAIN (Sore right arm), MYALGIA (Achy body) and FATIGUE (Tiredness). In November 2021, VACCINATION SITE PAIN (Sore right arm), MYALGIA (Achy body) and FATIGUE (Tiredness) had resolved.            No concomitant medications were provided.  On 05-Nov-2021, the patient had sore right arm, achy body and tiredness for a day and a half.  The patient received second Moderna COVID-19 vaccine booster dose on 20-May-2022 (batch no. 056M21A, vaccination site: right arm).  On 20-May-2022, the patient had sore right arm, achy body and tiredness for a day and a half.  No treatment medication was provided.   This case was linked to MOD-2022-666268, MOD-2022-666332, MOD-2022-666289 (Patient Link).
arm stiff; body ache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS and MYALGIA in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (arm stiff) and MYALGIA. The patient was treated with ALEVE at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS and MYALGIA outcome was unknown.            No concomitant medications provided.   Reporter did not allow further contact.
lightheadedness; diarrhea; restlessness,; confusion; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness), DIARRHOEA (diarrhea), RESTLESSNESS (restlessness,) and CONFUSIONAL STATE (confusion) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 040A21A) for COVID-19 vaccination.     Concomitant products included MEMANTINE HYDROCHLORIDE (NAMENDA), ASA, AMLODIPINE, ESCITALOPRAM, ATORVASTATIN, DONEPEZIL and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D NOS) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced DIZZINESS (lightheadedness), DIARRHOEA (diarrhea), RESTLESSNESS (restlessness,) and CONFUSIONAL STATE (confusion). At the time of the report, DIZZINESS (lightheadedness), DIARRHOEA (diarrhea), RESTLESSNESS (restlessness,) and CONFUSIONAL STATE (confusion) outcome was unknown. Not Provided          Treatment information was not provided. /unknown.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unspecified demographics. Information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was not provided. On unknown dates, the unspecified number of improperly stored doses of RECOMBIVAX HB lot # M032649, expiration date 11-NOV-2018 (dose, route of administration and anatomical location were not reported) were administered to the unspecified number of patients. No adverse effects were reported. The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccines were exposed to temperature of 29.7 degrees Fahrenheit for 60 days before administration to the patients. No previous temperature excursion was reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA012911: US-009507513-1705USA012910.
10/8/2019 Employee to Occ Health office c/o tenderness & enlarge "lymph node" to left neck area.  Measurements 2 fingers wide, and 1 finger long- very tender to touch. Afebrile with aches and not feeling well all weekend. Medical Director consulted and employee was advised to take Ibuprofen today and return to office 10/9. 10/9/2018 Employee returned to office with no improvement/ no changes- she is advised to see her PCP. 10/12/2018 Employee saw PCP who said this is a reaction from the flu shot. She is to continue ibuprofen and use an ice pack to the site.10/17/2018 She reported back to Occ Health that she is better, soreness gone and swelling is down tremendously.  She is to follow up with him if any further problems.
This spontaneous report as received from a pharmacist via a field employee refers to a 65 year old male patient. The patients concurrent conditions include diabetes mellitus. On 07-DEC-2015 the patient was vaccinated with ZOSTAVAX, vial dry SD, 0.65 ml, subcutaneous. Concomitant therapies included metformin and atenolol. On 07-DEC-2015, following vaccination, the patient experienced itching around the injection site for which the patient was not treated. No laboratory tests were reported. Cancer and overdose were not involved. No product quality complaint (PQC) was involved. The outcome of injection site pruritus was reported as not recovered/not resolved. Additional information has been requested.
Pain at injection site, could not lift arm at 7:30 PM on 10-13-17. Overnite on 10/13/17 I developed fever and chills, temperature 100.1. On 10-14-17, same sorenss, temperature and chills, fever hitting 100.4. General fatigue, malaise, and myalgia. On 10-15-17 symptoms somewhat improved.
Immunization 10/25/10 - 24 hours later swelling of lips. Lungs clear - no wheezing given oral BENADRYL 25mg & IM TAC 40mg.
7 days after first dose I experienced  itching, redness and swelling at the injection site.  I applied ice and took Benadryl & have continued for 4 days.  Redness and swelling abating as well as itching.
Redness, swelling, and rash starting at injection site and travelling down arm approximately 4 inches.